UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 139

Sortiert nach

Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis

Cell metabolism, 2019-01, Vol.29 (1), p.141-155.e9

2019

Volltextzugriff (PDF)

Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity

Obstetrics and gynecology (New York. 1953), 2012-01, Vol.119 (1), p.61-67

2012

Volltextzugriff (PDF)

Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube

Cancer discovery, 2016-12, Vol.6 (12), p.1342-1351

2016

Volltextzugriff (PDF)

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

The lancet oncology, 2013-02, Vol.14 (2), p.134-140

2013

Volltextzugriff (PDF)

The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy

Cancer, 2013-01, Vol.119 (2), p.325-331

2013

Volltextzugriff (PDF)

Gaps in patient-physician communication at the time of malignant bowel obstruction from recurrent gynecologic cancer: a qualitative study

Supportive care in cancer, 2022, Vol.30 (1), p.367-376

2022

Volltextzugriff (PDF)

International Gynecologic Cancer Society (IGCS) 2018: Meeting report

Gynecologic oncology, 2019-01, Vol.152 (1), p.7-10

2019

Volltextzugriff (PDF)

Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study

The lancet oncology, 2012-02, Vol.13 (2), p.154-162

2012

Volltextzugriff (PDF)

Geospatial patterns of access to self-care resources for obesity among endometrial cancer survivors in a high poverty urban community

Gynecologic oncology, 2019-02, Vol.152 (2), p.322-327

2019

Volltextzugriff (PDF)

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Journal of clinical oncology, 2011-01, Vol.29 (1), p.69-75

2011

Volltextzugriff (PDF)

Differences in Sociodemographic Disparities Between Patients Undergoing Surgery for Advanced Colorectal or Ovarian Cancer

Annals of surgical oncology, 2021-11, Vol.28 (12), p.7795-7806

2021

Volltextzugriff (PDF)

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Cancer, 2014-02, Vol.120 (3), p.344-351

2014

Volltextzugriff (PDF)

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study

Gynecologic oncology, 2013-04, Vol.129 (1), p.22-27

2013

Volltextzugriff (PDF)

ASO Visual Abstract: Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer

Annals of surgical oncology, 2021-12, Vol.28 (Suppl 3), p.430-431

2021

Volltextzugriff (PDF)

Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis

PloS one, 2014-08, Vol.9 (8), p.e104521-e104521

2014

Volltextzugriff (PDF)

A phase I study of weekly temsirolimus and topotecan in the treatment of advanced and/or recurrent gynecologic malignancies

Gynecologic oncology, 2010-06, Vol.117 (3), p.473-476

2010

Volltextzugriff (PDF)

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2010-01, Vol.28 (1), p.149-153

2010

Volltextzugriff (PDF)

Patterns and utility of routine surveillance in high grade endometrial cancer

Gynecologic oncology, 2015-06, Vol.137 (3), p.485-489

2015

Volltextzugriff (PDF)

Nanoscale Coordination Polymers Codeliver Chemotherapeutics and siRNAs to Eradicate Tumors of Cisplatin-Resistant Ovarian Cancer

Journal of the American Chemical Society, 2016-05, Vol.138 (18), p.6010-6019

2016

Volltextzugriff (PDF)

Approach to Palliative Care Consultation for Patients With Malignant Bowel Obstruction in Gynecologic Oncology: A Qualitative Analysis of Physician Perspectives

JCO oncology practice, 2020-08, Vol.16 (8), p.483-489

2020

Volltextzugriff (PDF)

Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention

Cancer prevention research (Philadelphia, Pa.), 2017-04, Vol.10 (4), p.255-266

2017

Volltextzugriff (PDF)

Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer

Cell, 2018-09, Vol.175 (1), p.159-170.e16

2018

Volltextzugriff (PDF)

Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group

Gynecologic oncology, 2011-02, Vol.120 (2), p.224-228

2011

Volltextzugriff (PDF)

A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: A gynecologic oncology group study

Gynecologic oncology, 2010-08, Vol.118 (2), p.139-144

2010

Volltextzugriff (PDF)

Nanomedicine for Combination Therapy of Cancer

EBioMedicine, 2015-05, Vol.2 (5), p.366-367

2015

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Publishing

KollektionSpringer Nature - Connect here FIRST to enable access

Zeitschrift / SerieGynecologic Oncology Reports

ThemaOvarian Neoplasms - Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(138)

Publikationsform

Sprache

Englisch
(139)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

Science & Technology
(87)
Life Sciences & Biomedicine
(85)
Humans
(76)
Female
(67)
Oncology
(64)
Middle Aged
(47)
Aged
(44)
Adult
(37)
Obstetrics & Gynecology
(34)
Biological And Medical Sciences
(32)
Medical Sciences
(31)
Tumors
(25)
Aged, 80 And Over
(24)
Gynecology. Andrology. Obstetrics
(21)
Female Genital Diseases
(19)
Hematology, Oncology And Palliative Medicine
(18)
Neoplasm Staging
(17)
Obstetrics And Gynecology
(16)
Disease-Free Survival
(15)
Ovarian Cancer
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis

Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity

Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy

Gaps in patient-physician communication at the time of malignant bowel obstruction from recurrent gynecologic cancer: a qualitative study

International Gynecologic Cancer Society (IGCS) 2018: Meeting report

Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study

Geospatial patterns of access to self-care resources for obesity among endometrial cancer survivors in a high poverty urban community

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Differences in Sociodemographic Disparities Between Patients Undergoing Surgery for Advanced Colorectal or Ovarian Cancer

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study

ASO Visual Abstract: Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer

Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis

A phase I study of weekly temsirolimus and topotecan in the treatment of advanced and/or recurrent gynecologic malignancies

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Patterns and utility of routine surveillance in high grade endometrial cancer

Nanoscale Coordination Polymers Codeliver Chemotherapeutics and siRNAs to Eradicate Tumors of Cisplatin-Resistant Ovarian Cancer

Approach to Palliative Care Consultation for Patients With Malignant Bowel Obstruction in Gynecologic Oncology: A Qualitative Analysis of Physician Perspectives

Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention

Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer

Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group

A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: A gynecologic oncology group study

Nanomedicine for Combination Therapy of Cancer

Aktive Filter

Suchergebnisse filtern